Long-Term Patient-Reported Outcomes from Monarche: Abemaciclib plus Endocrine Therapy for Adjuvant Hr+, Her2-, Node-Positive, High-Risk, Early Breast Cancer
AuthID
P-017-Q2A
P-017-Q2A
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service